NCT04951362

Role of Ivermectin Nanosuspension as Nasal Spray in Treatment of Persistant Post covid19 Anosmia

Studying the Expected Effect of Ivermectin Nanosuspension as Nasal Spray Upon Post covid19 Persistant Anosmia

• Status: Unknown
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 117 (estimated)
• Sponsor: South Valley University · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

ivermectin is FDA approaved antiparasitic drug which is also claimed to be having potent in vitro antiviral effect,so we are tryying to study itsovid19 anosmia effect upon releiving post covid19 anosmia

Detailed description

ivermectin is FDA approaved antiparasitic drug which is also claimed to be having potent in vitro antiviral effect,so we are tryying to study itsovid19 anosmia effect upon releiving post covid19 anosmia as one of the most characteresic symptoms of covid19 infection

Conditions

• Anosmia

Interventions

Type	Name	Description
DRUG	intranasal spray ivermectin	intranasal spray of saline

Timeline

• Start date: 2021-04-20
• Primary completion: 2022-05-12
• Completion: 2022-05-15
• First posted: 2021-07-06
• Last updated: 2022-04-22

Locations

1 site across 1 country: Egypt